OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

LZTR1 facilitates polyubiquitination and degradation of RAS-GTPases
Taiki Abe, Ikumi Umeki, Shin‐ichiro Kanno, et al.
Cell Death and Differentiation (2019) Vol. 27, Iss. 3, pp. 1023-1035
Open Access | Times Cited: 101

Showing 1-25 of 101 citing articles:

The role of ubiquitination and deubiquitination in cancer metabolism
Tianshui Sun, Zhuonan Liu, Qing Yang
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 328

Beyond K48 and K63: non-canonical protein ubiquitination
Michał Tracz, Wojciech Białek
Cellular & Molecular Biology Letters (2021) Vol. 26, Iss. 1
Open Access | Times Cited: 204

Diagnostic Pathology of Tumors of Peripheral Nerve
Sarra Belakhoua, Fausto J. Rodríguez
Neurosurgery (2021) Vol. 88, Iss. 3, pp. 443-456
Open Access | Times Cited: 96

The role of E3 ubiquitin ligases in the development and progression of glioblastoma
Luke Humphreys, Paul Smith, Zhuoyao Chen, et al.
Cell Death and Differentiation (2021) Vol. 28, Iss. 2, pp. 522-537
Open Access | Times Cited: 66

The molecular genetics of RASopathies: An update on novel disease genes and new disorders
Marco Tartaglia, Yoko Aoki, Bruce D. Gelb
American Journal of Medical Genetics Part C Seminars in Medical Genetics (2022) Vol. 190, Iss. 4, pp. 425-439
Open Access | Times Cited: 43

Integrative molecular and clinical profiling of acral melanoma links focal amplification of 22q11.21 to metastasis
Farshad Farshidfar, Kahn Rhrissorrakrai, Chaya Levovitz, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 41

Protein degradation: expanding the toolbox to restrain cancer drug resistance
Hui Ming, Bowen Li, Jingwen Jiang, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 30

Inhibition of ADAM9 promotes the selective degradation of KRAS and sensitizes pancreatic cancers to chemotherapy
Yukai Huang, Wei‐Chung Cheng, Ting-Ting Kuo, et al.
Nature Cancer (2024)
Closed Access | Times Cited: 8

Exquisitely Specific anti-KRAS Biodegraders Inform on the Cellular Prevalence of Nucleotide-Loaded States
Shuhui Lim, Regina Khoo, Yu‐Chi Juang, et al.
ACS Central Science (2020) Vol. 7, Iss. 2, pp. 274-291
Open Access | Times Cited: 66

Ubiquitin ligases in cancer: Functions and clinical potentials
Shanshan Duan, Michele Pagano
Cell chemical biology (2021) Vol. 28, Iss. 7, pp. 918-933
Open Access | Times Cited: 50

Post-translational modification of RAS proteins
Sharon L. Campbell, Mark R. Philips
Current Opinion in Structural Biology (2021) Vol. 71, pp. 180-192
Open Access | Times Cited: 50

The Ins and Outs of RAS Effector Complexes
Christina Kiel, David Matallanas, Walter Kölch
Biomolecules (2021) Vol. 11, Iss. 2, pp. 236-236
Open Access | Times Cited: 49

DAXX-ATRX regulation of p53 chromatin binding and DNA damage response
Nitish Gulve, Chenhe Su, Zhong Deng, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 30

Biological insights in non-small cell lung cancer
Rafael Rosell, Anisha Jain, Jordi Codony‐Servat, et al.
Cancer Biology and Medicine (2023), pp. 1-19
Open Access | Times Cited: 19

Recent Updates on the Significance of KRAS Mutations in Colorectal Cancer Biology
Loretta László, Anita Kurilla, Tamás Takács, et al.
Cells (2021) Vol. 10, Iss. 3, pp. 667-667
Open Access | Times Cited: 38

Impaired Proteolysis of Noncanonical RAS Proteins Drives Clonal Hematopoietic Transformation
Sisi Chen, Rahul S. Vedula, Antonio Cuevas-Navarro, et al.
Cancer Discovery (2022) Vol. 12, Iss. 10, pp. 2434-2453
Open Access | Times Cited: 23

Regulation of large and small G proteins by ubiquitination
Henrik Dohlman, Sharon L. Campbell
Journal of Biological Chemistry (2019) Vol. 294, Iss. 49, pp. 18613-18623
Open Access | Times Cited: 38

Epigenomic, genomic, and transcriptomic landscape of schwannomatosis
Sheila Mansouri, Suganth Suppiah, Yasin Mamatjan, et al.
Acta Neuropathologica (2020) Vol. 141, Iss. 1, pp. 101-116
Open Access | Times Cited: 38

The Ubiquitin–Proteasome System in Tumor Metabolism
Jie Wang, Yuandi Xiang, Mengqi Fan, et al.
Cancers (2023) Vol. 15, Iss. 8, pp. 2385-2385
Open Access | Times Cited: 12

Mutation-induced LZTR1 polymerization provokes cardiac pathology in recessive Noonan syndrome
Alexandra Viktoria Busley, Óscar Gutiérrez‐Gutiérrez, Elke Hammer, et al.
Cell Reports (2024) Vol. 43, Iss. 7, pp. 114448-114448
Open Access | Times Cited: 4

Anti-proteolytic regulation of KRAS by USP9X/NDRG3 in KRAS-driven cancer development
Han Koo, Kyung Chan Park, Hyun Ahm Sohn, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access

The tumor suppressor LZTR1: Its expression, purification and characterization
Yifang Sun, Yuxuan Jiang, Meng Zhang, et al.
Protein Expression and Purification (2025), pp. 106716-106716
Closed Access

Josephin Domain Containing 2 (JOSD2) inhibition as Pan-KRAS-mutation-targeting strategy for colorectal cancer
Tao Yuan, Yue Liu, Ruilin Wu, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access

Page 1 - Next Page

Scroll to top